TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

67.20

-0.63 (-0.93%)

At close: May 29, 2026, 4:00 PM EDT

67.22

+0.02 (0.03%)

After-hours: May 29, 2026, 7:58 PM EDT

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	635.89	605.49	441.54	241.62	93.46	30.26
Revenue Growth (YoY)	30.25%	37.13%	82.74%	158.53%	208.83%	18.03%
Cost of Revenue	260.15	242.69	179.46	87.53	28.19	9.1
Gross Profit	375.74	362.81	262.08	154.09	65.27	21.16
Selling, General & Admin	204.53	185.17	168.62	119.55	69.9	38.28
Research & Development	76.77	69.06	55.97	27.21	26.81	22.3
Total Operating Expenses	281.3	254.22	224.59	146.77	96.71	60.59
Operating Income	94.44	108.58	37.5	-28.73	-31.44	-39.43
Interest Income	12.39	12.72	12.69	12.85	-1	-0.88
Interest Expense	-17.49	-13.78	-14.41	-10.79	-3.73	-3.87
Total Non-Operating Income (Expense)	-5.11	-1.06	-1.72	2.06	-4.73	-4.75
Pretax Income	89.33	107.52	35.78	-26.67	-36.17	-44.18
Provision for Income Taxes	-82.59	-82.77	0.32	-1.64	0.07	0.04
Net Income	171.92	190.29	35.46	-25.03	-36.23	-44.22
Net Income to Common	171.92	190.29	35.46	-25.03	-36.23	-44.22
Net Income Growth	251.23%	436.58%	-	-	-	-
Shares Outstanding (Basic)	34	34	33	33	30	28
Shares Outstanding (Diluted)	40	41	35	33	30	28
Shares Change (YoY)	8.44%	15.12%	8.30%	10.02%	7.02%	11.80%
EPS (Basic)	5.03	5.60	1.07	-0.77	-1.23	-1.60
EPS (Diluted)	4.40	4.87	1.01	-0.77	-1.23	-1.60
EPS Growth	223.53%	382.18%	-	-	-	-
Shares Outstanding	34.55	34.27	33.62	32.67	32.14	27.79
Free Cash Flow	151.36	133.59	-80.94	-164.88	-57.72	-32.38
Free Cash Flow Growth	13.30%	-	-	-	-	-
Free Cash Flow Per Share	3.82	3.30	-2.30	-5.07	-1.95	-1.17
Gross Margin	59.09%	59.92%	59.36%	63.77%	69.84%	69.92%
Operating Margin	14.85%	17.93%	8.49%	-11.89%	-33.64%	-130.29%
Profit Margin	27.04%	31.43%	8.03%	-10.36%	-38.77%	-146.11%
FCF Margin	23.80%	22.06%	-18.33%	-68.24%	-61.76%	-107.01%
EBITDA	127.35	135.77	57.25	-20.55	-27.96	-37.61
EBITDA Margin	20.03%	22.42%	12.97%	-8.50%	-29.92%	-124.28%
EBIT	94.44	108.58	37.5	-28.73	-31.44	-39.43
EBIT Margin	14.85%	17.93%	8.49%	-11.89%	-33.64%	-130.29%
Effective Tax Rate	-92.46%	-76.98%	0.88%	6.16%	-0.18%	-0.08%

SEC Filings: 10-K · 10-Q